India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Expands manufacturing push & locks in major growth deals
The standout story remains Wegovy, particularly its new oral formulation
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
Subscribe To Our Newsletter & Stay Updated
